Trish Wood

Trish Wood is Critical

Trish Wood

  • Special Panel: Edward Dowd, Kelly Brown and Jessica Rose

Special Panel: Edward Dowd, Kelly Brown and Jessica Rose

Saturday 30th July 2022

Join Trish Wood and her panel as they discuss Covid-19 vaccine safety and efficacy, exploring data on excess deaths and adverse reactions.
123 minutes
Informative
Thought-provoking
Raw
Engaging
Eye-opening

About this podcast

Trish Wood is Critical
Author:
Trish Wood
Overview:
Categories:
Sexual Stigmas & Myths
Recovery from Trauma
Cultural Commentary
Sobriety Toolkit
Relationships & Community
Links:
Visit site
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Questioning Covid-19 Vaccine Safety: Insights from Edward Dowd, Kelly Brown, and Jessica Rose

We’re at over 6 million reports [of adverse events], and this is only what’s been reported and filed in the front-end system.
Is it time to rethink our stance on Covid-19 vaccines? In this episode of 'Trish Wood is Critical', award-winning journalist Trish Wood brings together a panel of thought-provoking guests to discuss the pressing concerns surrounding vaccine safety and efficacy. Former hedge fund manager Edward Dowd, investor Kelly Brown, and independent researcher Jessica Rose share their perspectives on the data that has emerged since the vaccines were mandated.
They dive into the numbers, discussing the rise in excess deaths and adverse reactions that have been reported. This episode doesn't shy away from the tough questions: Are these vaccines as effective as initially promised? What are the potential risks we need to consider? The panelists emphasize the importance of critical thinking and transparency in evaluating the data and making informed decisions.
Whether you're skeptical about vaccines or simply curious about the ongoing debate, this episode offers a comprehensive look at the complexities involved. Tune in for a candid conversation that challenges conventional narratives and encourages deeper reflection on public health policies.